ETAGX (ETAGX) Stock Price & Analysis
ETAGX (ETAGX) fell 1.75% to USD 59.54 as of June 10, 2026 at 21:20 UTC, according to Nexqual real-time market data.
ETAGX last closed at USD 60.6; the session ranged USD 59.54–59.54 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.37–61.98 (NAS). Source: Nexqual, June 10, 2026 at 21:20 UTC.
Key Statistics (as of June 10, 2026 at 21:20 UTC)
| Price | USD 59.54 |
|---|---|
| Change | ▼ 1.75% (down) |
| Previous Close | USD 60.6 |
| Open | USD 59.54 |
| Day Range | USD 59.54 – 59.54 |
| 52-Week Range | USD 48.37 – 61.98 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETAGX)
Nexqual's technical model rates ETAGX "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 21:20 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.06 (neutral) |
| vs SMA50 | Above (USD 56.53) |
| MACD | 1.2 (positive) |
Financial Health Score (ETAGX)
Nexqual rates ETAGX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 21:20 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETAHX | Eventide Healthcare & Life Scie | USD 46.39 | ▲ 0.41% |
| ETILX | Eventide Gilead Fund Institutio | USD 62.72 | ▼ 1.15% |
| ETGLX | Eventide Gilead Fund | USD 60.1 | ▼ 1.14% |
| ETCGX | Eventide Gilead Fund Class C | USD 50.06 | ▼ 1.15% |
| TLVAX | Timothy Plan Large/Mid Cap Valu | USD 23.14 | ▼ 0.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 21:20 UTC. This page is informational and not investment advice.